Povidone Iodine (PVP-I) mouth gargle/nasal spray may be the simplest and cost effective therapeutic antidote for COVID-19 Frontier
Article Sidebar
Main Article Content
Abstract
Need an effective protocol for health workers against dangerous and unpredictable SARS CoV-2, a RNA lipid bi-layer enveloped beta-coronaviruses which contains Hemagglutinin Esterase (HE) protein binds with human gene through Angiotensin-Converting-Enzyme 2 (ACE2) and CD147 receptor. Povidone-iodine (PVP-I) has effective virucidal activity by those receptors inhibition and direct kill the virus by membrane disruption. PVP-I gargle, nasal spray and eye drop in case of accidental exposure is well tolerated easy use and has 2-3 hours contamination protection properties. So, uses gargle and nasal spray every 3 hours during shifting duty of health care provider which will cover the total protection and reduced social contamination.
Downloads
Article Details
Copyright (c) 2020 Khalil I, et al.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Kirk-Bayley J, Sunkaraneni S, Challacombe S (2020) The Use of Povidone Iodine Nasal Spray and Mouthwash During the Current COVID-19 Pandemic May Reduce Cross Infection and Protect Healthcare Workers. Link: https://bit.ly/2ZHbX3E
Pattanshetty S, Narayana A, Radhakrishnan R (2020) Povidone‐iodine gargle as a prophylactic intervention to interrupt the transmission of SARS‐CoV‐2. Oral Diseases. Link: https://bit.ly/2CSwCZw
Wang K, Chen W, Zhou YS, Lian JQ, Zhang Z, et al. (2020) SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. Bio Rxiv preprint. Link: https://bit.ly/3eREs3e
Yan R, Zhang Y, Li Y, Xia L, Guo Y, et al. (2020) Structural basis for the recognition of the SARS-CoV2 by full-length human ACE2. Science 367: 1444-1448. Link: https://bit.ly/2ZJmhYR
Lange C, Wolf J, Auw‐Haedric C, Schlecht A, Boneva S, et al. (2020) J Med Virol 1-6. Link: https://bit.ly/2OFqvup
Sarma P, Kaur H, Kaur H, Bhattacharyya J, Prajapat M, et al. (2020) Ocular manifestations and tear or conjunctival swab PCR positivity for 2019-nCoV in patients with COVID-19: a systematic review and metaanalysis. Soc Sci Res Netw. Link: https://bit.ly/2OCT1ga
Zhou Y, Zeng Y, Tong Y, Chen C (2020) Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. Ophthalmology . Link: https://bit.ly/32zL17N
Wu P, Duan F, Luo C, Liu Q, Qu X (2020) Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 138: 575-578. Link: https://bit.ly/3hj4n5e
Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, et al. (2020) Drug targets for corona virus: a systematic review. Indian J Pharmacol 52: 56-65. Link: https://bit.ly/2ZHas5E
Sarma P, Prajapat M, Avti P, Kaur H, Kumar S, et al. (2020) Therapeutic options for the treatment of 2019-novel coronavirus: an evidence-based approach. Indian J Pharmacol 52: 1 -5. Link: https://bit.ly/39dmMNY
Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 1282: 1-23. Link: https://bit.ly/32D74L8
Sriwilaijaroen N, Wilairat P, Hiramatsu H, Takahashi T, Suzuki T, et al. (2009) Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities. Virol J 6: 124. Link: https://bit.ly/2OFrqel
Park SE (2020) Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). 63: 119-124. Link: https://bit.ly/30y1Ey2
Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, et al. (2020) Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181: 281-292.e6. Link: https://bit.ly/30wkRQC
COVID-19 : Povidone iodine intranasal Prophylaxis in Front-line Healthcare Personal and Inpatients (PIIPPI) ClinicalTrials. gov Identifier: NCT04364802. Link: https://bit.ly/3fRv7K4
Godlee F (2020) Protect our healthcare workers. BMJ 369. Link: https://bit.ly/32zMCKP
Akram A, Mannan N (2020) Molecular Structure, Pathogenesis and Virology of SARSCoV-2: A Review. Bangladesh J Infect Dis7: S36-S40. Link: https://bit.ly/2E1ub7K
Eggers M (2019) Infectious Disease Management and Control with Povidone Iodine. Infect Dis Ther 8: 581-593. Link: https://bit.ly/30wrFxF
Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD (2020) SARS-CoV2 and Coronavirus Disease 2019: What We Know So Far. Pathogens 9: 231. Link: https://bit.ly/3fLWwwO
Sarma P, Kaur H, Medhi B, Bhattacharyya A (2020) Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV. Graefe's Archive for Clinical and Experimental Ophthalmology. Link: https://bit.ly/3fLYkWv
Pepose JS, Ahuja A, Liu W, Narvekar A, Haque R (2018) Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis. Am J Ophthalmol 194: 7-15. Link: https://bit.ly/3hh0Y6V
Kovalyuk N, Kaiserman I, Mimouni M, Cohen O, Levartovsky S, et al. (2017) Treatment of adenoviral keratoconjunctivitis with a combination of povidoneiodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol 95: e686-e692. Link: https://bit.ly/3jtyKYT
Pinto RDP, Lira RPC, Abe RY, Zacchia RS, Felix JPF, et al. (2015) Dexamethasone/ povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial. Curr Eye Res 40: 870-877. Link: https://bit.ly/3eP1Cae
Waikar S, Oli A (2020) COVID-19: Ophthalmic prophylactic and therapeutic measures. Indian J Ophthalmol 68: 1223-1224. Link: https://bit.ly/2Cu04Fz
Kursumovic E, Lennane S, Cook TM (2020) Deaths in healthcare workers due to COVID‐19: the need for robust data and analysis. Anaesthesia. Link: https://bit.ly/2WCOLlr
Neto MLR, Almeida HG, Esmeraldo JD, Nobre CB, Pinheiro WR, et al. (2020) When health professionals look death in the eye: the mental health of professionals who deal daily with the 2019 coronavirus outbreak. Psychiatry Res 288: 112972. Link: https://bit.ly/30xqQ89
Shiraishi T, Nakagawa Y (2002) Evaluation of the bactericidal activity of povidone-iodine and commercially available gargle preparations. Dermatology (Basel, Switzerland) 204: 37-41. Link: https://bit.ly/39dwIXP
Bigliardi PL, Alsagoff SAL, El-Kafrawi HY, Pyon JK, Wa CTC, et al. (2017) Povidone iodine in wound healing: A review of current concepts and practices. International Journal of Surgery 44: 260–268. Link: https://bit.ly/2E10fbU
Pelletier JS, Tessema B, Westover J, Frank S, Brown SM, et al. (2020) In Vitro Efficacy of Povidone-Iodine Nasal And Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). Link: https://bit.ly/2CUj5kw
Ader AW, Paul TL, Reinhardt W, Safran M, Pino S, et al. (1988) Effect of mouth rinsing with two polyvinylpyrrolidone-iodine mixtures on iodine absorption and thyroid function. Journal of Clinical Endocrinology and Metabolism 66: 632-635. Link: https://bit.ly/2BgEYKj
Link: https://bit.ly/3huCWpt
Smith H (2020) Clinical Trial Looks at Antiseptic Nasal Spray and Gargle to Prevent COVID-19 Infections, University of Kentucky news. Link: https://bit.ly/3hg6BT1
Sabracos L, Romanou S, Dontas I, Coulocheri S, Ploumidou K, et al. (2006) The in vitro effective antiviral action of povidone– iodine (PVP–I) may also have therapeutic potential by its intravenous administration diluted with Ringer’s solution. Med Hypotheses 68: 272-274. Link: https://bit.ly/3eNgXbn
O’Donnell VB, Thomas D, Stanton R, Maillard JY, Murphy RC, et al. (2020) Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection. 1. Link: https://bit.ly/2DUWZyA
Clement C, Capriotti JA, Kumar M, Hobden JA, Foster TP, et al. (2011) Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci 52: 339-344. Link: https://bit.ly/30mBaiU
Chakrabarty C (2020) Corona changed gene structure 380 times, found human body in friend Jean, quid reveals mystery Bengali scientist.
Anderson DE, Sivalingam V, Kang AEZ, Ananthanarayanan A, Arumugam H, et al. (2020) Povidone-iodine demonstrates rapid in-vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease. Link: https://bit.ly/39kcJH5
Rahman S, Bahar T (2020) COVID-19: The New Threat. Int J Infect 7: e102184. Link: https://bit.ly/2OHAYFS